GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Numeral Ltd (JSE:GLI) » Definitions » Debt-to-Revenue

Numeral (JSE:GLI) Debt-to-Revenue : N/A (As of Nov. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Numeral Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Numeral's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was R2.96 Mil. Numeral's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was R0.00 Mil. Numeral's annualized Revenue for the quarter that ended in Nov. 2023 was R0.00 Mil.


Numeral Debt-to-Revenue Historical Data

The historical data trend for Numeral's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numeral Debt-to-Revenue Chart

Numeral Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Feb18 Feb19 Feb20 Feb21 Feb22
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.88 N/A N/A N/A N/A

Numeral Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 Nov19 Feb20 Aug20 Nov20 Feb21 Aug21 Nov21 Feb22 Aug22 Nov22 Aug23 Nov23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Numeral's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Numeral's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Numeral's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Numeral's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Numeral's Debt-to-Revenue falls into.



Numeral Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Numeral's Debt-to-Revenue for the fiscal year that ended in Feb. 2022 is calculated as

Numeral's annualized Debt-to-Revenue for the quarter that ended in Nov. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Nov. 2023) Revenue data.


Numeral Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Numeral's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Numeral (JSE:GLI) Business Description

Traded in Other Exchanges
Address
142, Mosque Road, Midlands, MUS
Go Life International PCC is an investment holding group. It is principally engaged in the distribution of health products including natural products, supplements, and cosmeceuticals.

Numeral (JSE:GLI) Headlines

No Headlines